Find Ataciguat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 254877-67-3, Hmr-1766, Ataciguat [inn], Hmr1766, Qp166m390q, 5-chloro-2-[(5-chlorothiophen-2-yl)sulfonylamino]-n-(4-morpholin-4-ylsulfonylphenyl)benzamide
Molecular Formula
C21H19Cl2N3O6S3
Molecular Weight
576.5  g/mol
InChI Key
PQHLRGARXNPFCF-UHFFFAOYSA-N
FDA UNII
QP166M390Q

Ataciguat
Ataciguat has been investigated for the basic science of Aortic Valve Stenosis.
1 2D Structure

Ataciguat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-chloro-2-[(5-chlorothiophen-2-yl)sulfonylamino]-N-(4-morpholin-4-ylsulfonylphenyl)benzamide
2.1.2 InChI
InChI=1S/C21H19Cl2N3O6S3/c22-14-1-6-18(25-34(28,29)20-8-7-19(23)33-20)17(13-14)21(27)24-15-2-4-16(5-3-15)35(30,31)26-9-11-32-12-10-26/h1-8,13,25H,9-12H2,(H,24,27)
2.1.3 InChI Key
PQHLRGARXNPFCF-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl
2.2 Other Identifiers
2.2.1 UNII
QP166M390Q
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide

2. Hmr 1766

3. Hmr-1766

4. Hmr1766

2.3.2 Depositor-Supplied Synonyms

1. 254877-67-3

2. Hmr-1766

3. Ataciguat [inn]

4. Hmr1766

5. Qp166m390q

6. 5-chloro-2-[(5-chlorothiophen-2-yl)sulfonylamino]-n-(4-morpholin-4-ylsulfonylphenyl)benzamide

7. 5-chloro-2-[[(5-chloro-2-thienyl)sulfonyl]amino]-n-[4-(4-morpholinylsulfonyl)phenyl]benzamide

8. 5-chloro-2-((5-chloro-2-thienyl)sulfonylamino)-n-(4-(morpholin-4-ylsulfonyl)phenyl)benzamide

9. Dsstox_cid_28672

10. Dsstox_rid_82942

11. Dsstox_gsid_48746

12. Hmr 1766

13. Cas-254877-67-3

14. Unii-qp166m390q

15. 5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide

16. Ataciguat [who-dd]

17. Schembl491675

18. Gtpl5141

19. Chembl2107729

20. Dtxsid7048746

21. Zinc3612878

22. Tox21_113203

23. Tox21_113203_1

24. Db12805

25. Sb16944

26. Ncgc00249417-01

27. Ncgc00249417-02

28. Hy-17500

29. Cs-0009242

30. Ft-0662311

31. A911275

32. J-016012

33. Q27074574

34. 5-chloro-2-(5-chlorothiophene-2-sulfonamido)-n-[4-(morpholine-4-sulfonyl)phenyl]benzamide

2.4 Create Date
2005-08-09
3 Chemical and Physical Properties
Molecular Weight 576.5 g/mol
Molecular Formula C21H19Cl2N3O6S3
XLogP34.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count7
Exact Mass574.9813042 g/mol
Monoisotopic Mass574.9813042 g/mol
Topological Polar Surface Area167 Ų
Heavy Atom Count35
Formal Charge0
Complexity944
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Enzyme Activators

Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty